CClinicalTrials.gg
CompletedNCT01836419Updated Feb 19, 2014

The Clinical Efficacy of Laryngeal Mask Airway in Elderly Patients: Comparison With Young Adults

An interventional study of classic LMA insertion in Minor Urologic Surgery and Lower Extremity Surgery, sponsored by Yonsei University. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-02-19.

Sponsored by Yonsei University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
20 Years to 85 Years
Sex
All
01

Study summary

There are some differences between elderly and young adult patients regarding the anatomy of upper airways. Elderly patients have larger upper airways than young adult patients at all pharyngeal levels as revealed by CT. Another study explained that there is a progressive descent of the larynx and epiglottis with aging, which lengthens the upper airway and possibly makes it more likely to collapse.

The aim of this study is to compare the clinical efficacy of laryngeal mask airway (LMA) in elderly patients with young adults. In this study, the investigators will measure the ease of insertion, success rate of insertion, the time of insertion, oropharyngeal leak pressure, gastric leak pressure, fiberoptic position and intraoperative complications of the classic LMA.

02

Conditions studied

  • Minor Urologic Surgery
  • Lower Extremity Surgery

Keywords

  • classic laryngeal mask airway
  • elderly patients
03

In context

Lead sponsor

Yonsei University is the lead sponsor of 1,387 studies on the registry; 232 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 20-40 and 65-85years
  • ASA status 1-2
  • Undergoing minor urologic surgery or lower extremity surgery
  • Undergoing general anesthesia using classic LMA

Exclusion criteria

Exclusion Criteria:

  • Predicted difficult airway
  • Increased risk of aspiration
  • Gastroesophageal reflux
  • Neuromuscular disease
  • Significant acute or chronic lung disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    young adult group

    young adult patients undergoing minor urologic surgery or lower extremity surgery

    Procedure: classic LMA insertion

  • Active comparator
    elderly group

    elderly patients undergoing minor urologic surgery or lower extremity surgery

    Procedure: classic LMA insertion

Interventions

  • Procedureclassic LMA insertion
06

What researchers measure

Primary outcomes

  1. oropharyngeal leak pressure

    After successful placement of LMA, airway leak pressure was determined by adjusting the expiratory valve of the breathing circle to 40 cmH2O(fixed fresh gas flow 3 L/min) and recording the pressure when equilibrium was reached.

    Time frame: 24 hours

07

Study locations

1 site
  • Severance hospital
    Seoul, 120-752, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01836419
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Apr 19, 2013
Start date
Dec 2012
Primary completion
Nov 2013
Completion
Nov 2013
Last update
Feb 19, 2014

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion